EYESW - (Second Sight Medical Products Inc.)

 EYESWのチャート


 EYESWの企業情報

symbol EYESW
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear ―年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/eyesw
adr_tso
EBITDA EBITDA ー
終値(lastsale) 0.45
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 EYESWのテクニカル分析


 EYESWのニュース

   Mid-Day Market Update: Crude Oil Rises 3.5%; Second Sight Medical Products Shares Plunge  2021/03/24 12:29:00 Benzinga
Midway through trading Wednesday, the Dow traded up 1.04% to 32,760.03 while the NASDAQ rose 0.08% to 13,238.38. The S&P also rose, gaining 0.70% to …
   Second Sight Medical Products (EYES) shares rise 1,000%. Should I buy?  2021/03/10 13:25:58 The Motley Fool UK
Jonathan Smith takes a look at EYES shares following FDA product approval and the sharp move higher in the price in March so far. The post Second Sight Medical Products (EYES) shares rise 1,000%. Should I buy? appeared first on The Motley Fool UK .
   The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link  2021/03/10 12:25:58 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 9) Amneal Pharmaceuticals, Inc. (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC ) ( announced a new-gen multi-cancer detection sensor) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX ) Bausch Health Companies Inc. (NYSE: BHC ) (issued a pipeline update at a conference) Bolt Biotherapeutics, Inc. (NASDAQ: BOLT ) Cullinan Oncology, Inc. (NASDAQ: CGEM ) Five Prime Therapeutics, Inc. (NASDAQ: FPRX ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS ) (reacted to its fourth-quarter results) Second Sight Medical Products, Inc. (NASDAQ: EYES ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Surmodics, Inc. (NASDAQ: SRDX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 9) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) (moved lower in reaction to FDA communication regarding deficiencies in its regulatory application for dementia drug) Immunocore Holdings plc (NASDAQ: IMCR ) Stocks In Focus MediciNova Gets BARDA Contract to Study MN-166 For Chlorine Gas-induced Lung Damage MediciNova, Inc. (NASDAQ: MNOV ) said it has partnered with the BARDA to repurpose MN-166 as a potential medical countermeasure against chlorine gas-induced lung damage such as acute respiratory distress syndrome and acute lung injury.
   66 Biggest Movers From Yesterday  2021/03/09 10:03:09 Benzinga
Gainers Second Sight Medical Products, Inc. (NASDAQ: EYES ) shares surged … Full story available on Benzinga.com
   Why Second Sight Medical Products Has Skyrocketed 723% In 2 Trading Sessions  2021/03/09 03:39:36 Benzinga
Second Sight Medical Products Inc (NASDAQ: EYES ) shares have soared above 723% over the previous two trading sessions with the stock touching an intraday high of $14.83 on Monday. The shares registered a spike of nearly 103% as of Monday’s closing. What Happened: The California-based developer and marketer of implantable visual prosthetics said on Friday that the United States Food and Drug Administration had approved its Argus 2s Retinal Prosthesis System. The Argus 2s is used for the treatment … Full story available on Benzinga.com
   Second Sight Medical Products (EYES) shares rise 1,000%. Should I buy?  2021/03/10 13:25:58 The Motley Fool UK
Jonathan Smith takes a look at EYES shares following FDA product approval and the sharp move higher in the price in March so far. The post Second Sight Medical Products (EYES) shares rise 1,000%. Should I buy? appeared first on The Motley Fool UK .
   The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link  2021/03/10 12:25:58 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 9) Amneal Pharmaceuticals, Inc. (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC ) ( announced a new-gen multi-cancer detection sensor) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX ) Bausch Health Companies Inc. (NYSE: BHC ) (issued a pipeline update at a conference) Bolt Biotherapeutics, Inc. (NASDAQ: BOLT ) Cullinan Oncology, Inc. (NASDAQ: CGEM ) Five Prime Therapeutics, Inc. (NASDAQ: FPRX ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS ) (reacted to its fourth-quarter results) Second Sight Medical Products, Inc. (NASDAQ: EYES ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Surmodics, Inc. (NASDAQ: SRDX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 9) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) (moved lower in reaction to FDA communication regarding deficiencies in its regulatory application for dementia drug) Immunocore Holdings plc (NASDAQ: IMCR ) Stocks In Focus MediciNova Gets BARDA Contract to Study MN-166 For Chlorine Gas-induced Lung Damage MediciNova, Inc. (NASDAQ: MNOV ) said it has partnered with the BARDA to repurpose MN-166 as a potential medical countermeasure against chlorine gas-induced lung damage such as acute respiratory distress syndrome and acute lung injury.
   66 Biggest Movers From Yesterday  2021/03/09 10:03:09 Benzinga
Gainers Second Sight Medical Products, Inc. (NASDAQ: EYES ) shares surged … Full story available on Benzinga.com
   Why Second Sight Medical Products Has Skyrocketed 723% In 2 Trading Sessions  2021/03/09 03:39:36 Benzinga
Second Sight Medical Products Inc (NASDAQ: EYES ) shares have soared above 723% over the previous two trading sessions with the stock touching an intraday high of $14.83 on Monday. The shares registered a spike of nearly 103% as of Monday’s closing. What Happened: The California-based developer and marketer of implantable visual prosthetics said on Friday that the United States Food and Drug Administration had approved its Argus 2s Retinal Prosthesis System. The Argus 2s is used for the treatment … Full story available on Benzinga.com
   Second Sight Medical stock skyrockets 8-fold in 2 days after FDA approves retinal prosthesis system  2021/03/08 17:16:00 MarketWatch
Shares of Second Sight Medical Products Inc. undefined soared 104.2% on heavy volume in midday trading Monday, bringing its two-day gain to 728.7%, after the…

 関連キーワード  (― 米国株 EYESW Second Sight Medical Products Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)